Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegliadine Fumarate vs Sufentanil for PONV and Analgesia After Gynecologic Laparoscopy
ChiCTR2500113795Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Taizhou First People's Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegliadine fumarate in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by Department of Anesthesiology, Taizhou First People's Hospital. Primary endpoint: Visual Analog Scale Score for Postoperative Nausea and Vomiting. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
tegliadine fumarate
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on ChiCTR2500113795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113795.